These modifications create a orange-peel appearance on the thighs, hips, or buttocks, particularly common in women
with insulin and GLP-1 and GIP analogues) has been associated with temporary worsening of diabetic retinopathy (disease of the retina secondary to diabetes)[19]
Dose Escalation Phase (4-12 Weeks) In this phase, the dose is increased gradually to 1 mg, 1.5 mg, and 1.7 mg per week, depending on how well the body tolerates the medication
In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide lost an average of 22.5 percent of their body weight at 72 weeks (Jastreboff et al., NEJM , 2022), compared to roughly 15 percent with semaglutide 2.4 mg in the STEP 1 trial (Wilding et al., NEJM , 2021)
Additionally, L-carnitine demonstrates recovery benefits by reducing exercise-induced muscle damage markers and accelerating the clearance of metabolic byproducts that contribute to fatigue and soreness